Opaleye Management Inc. Cti Biopharma Corp Transaction History

Opaleye Management Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 May 15, 2019	SELL	$0.9 - $1.37 $1.26 Million - $1.92 Million	-1,400,000 Closed	0 $0
Q4 2018 Feb 14, 2019	SELL	$0.73 - $2.19 $109,500 - $328,500	-150,000 Reduced 9.68%	1,400,000 $1.03 Million
Q3 2018 Nov 14, 2018	BUY	$1.72 - $5.24 $2.39 Million - $7.28 Million	1,388,600 Added 860.35%	1,550,000 $3.35 Million
Q2 2018 Aug 14, 2018	BUY	$3.81 - $5.26 $614,934 - $848,964	161,400 New	161,400 $803,000

Ticker CTIC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 114,385,000
Market Cap $1.04B
Description
CTI BioPharma Corp., a biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel targeted therapies for blood-related cancers in the United States. It offers VONJO (pacritinib), an investigational oral kinase inhibitor with specificity for JAK2, FLT3, IRAK1, and CSF1R for the treatment of adult patients w...

Get notified when there are updates to the investment portfolio of Opaleye Management Inc., based on Form 13F filings with the SEC.

Stay updated on Opaleye Management Inc. with notifications on news.